EA202191212A1 - Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам - Google Patents

Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам

Info

Publication number
EA202191212A1
EA202191212A1 EA202191212A EA202191212A EA202191212A1 EA 202191212 A1 EA202191212 A1 EA 202191212A1 EA 202191212 A EA202191212 A EA 202191212A EA 202191212 A EA202191212 A EA 202191212A EA 202191212 A1 EA202191212 A1 EA 202191212A1
Authority
EA
Eurasian Patent Office
Prior art keywords
biofilms
compositions
methods
processing
drug resistance
Prior art date
Application number
EA202191212A
Other languages
English (en)
Russian (ru)
Inventor
Геир Хермод Алмас
Original Assignee
Виаб Вотер Инновейшн Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виаб Вотер Инновейшн Аб filed Critical Виаб Вотер Инновейшн Аб
Publication of EA202191212A1 publication Critical patent/EA202191212A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B11/00—Oxides or oxyacids of halogens; Salts thereof
    • C01B11/04—Hypochlorous acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA202191212A 2018-11-02 2019-11-01 Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам EA202191212A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862755104P 2018-11-02 2018-11-02
PCT/IB2019/001231 WO2020089693A1 (en) 2018-11-02 2019-11-01 Compositions for treating biofilms without inducing antimicrobial resistance

Publications (1)

Publication Number Publication Date
EA202191212A1 true EA202191212A1 (ru) 2021-09-17

Family

ID=69165410

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191212A EA202191212A1 (ru) 2018-11-02 2019-11-01 Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам

Country Status (13)

Country Link
EP (1) EP3873450A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022506394A (cg-RX-API-DMAC7.html)
KR (1) KR20220027799A (cg-RX-API-DMAC7.html)
CN (1) CN113747889A (cg-RX-API-DMAC7.html)
AU (1) AU2019371088A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021008550A2 (cg-RX-API-DMAC7.html)
CA (1) CA3118187A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021001141A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191212A1 (cg-RX-API-DMAC7.html)
IL (1) IL282819A (cg-RX-API-DMAC7.html)
MX (1) MX2021005136A (cg-RX-API-DMAC7.html)
PH (1) PH12021551010A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020089693A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675299B2 (en) 2012-02-17 2020-06-09 Wiab Water Innovation Ab Hand disinfectant
US12551501B2 (en) 2012-02-17 2026-02-17 Wiab Water Innovation Ab Compositions and methods for treating biofilms without inducing antimicrobial resistance
US12115185B2 (en) 2012-02-17 2024-10-15 Wiab Water Innovation Ab Compositions of hypochlorous acid and methods of manufacture thereof
US11364262B2 (en) 2012-02-17 2022-06-21 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of skin trauma
US11357794B2 (en) 2012-02-17 2022-06-14 Wiab Wafer Innovation Ab Preparations for controlled-release of hypochlorous acid
EP2814776B1 (en) 2012-02-17 2018-04-11 Wiab Water Innovation AB Compositions of hypochlorous acid (hoci) and methods of manufacture thereof
BR112023000427A2 (pt) * 2020-07-07 2023-03-28 Wiab Water Innovation Ab Composições e métodos para desinfectar, tratar e prevenir infecções microbianas
US12611425B2 (en) 2022-10-10 2026-04-28 Wiab Water Innovation Ab Compositions and methods for treatment and prevention of pathogens
EP4458343B1 (de) 2023-05-04 2025-04-09 Heraeus Medical GmbH Vorrichtung zur präparation und abgabe einer antiseptischen wundspüllösung
EP4506000A1 (de) 2023-08-08 2025-02-12 Heraeus Medical GmbH Antiseptisches kit und dessen verwendung
EP4585254A1 (de) 2024-01-09 2025-07-16 Heraeus Medical GmbH Wundspüllösung zur entfernung von biofilmen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113854A (en) 1977-01-10 1978-09-12 Minnesota Mining And Manufacturing Company Prophylactic treatment of mastitis
GB8730107D0 (en) 1987-12-24 1988-02-03 Diversey Corp Treatment of mastitis & applicator therefor
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5797872A (en) 1996-04-26 1998-08-25 Nippon Ozone Co., Ltd. Method of treating domestic animals such as cows for mastitis and apparatus for injecting ozone into breasts
US20010036482A1 (en) 1999-10-15 2001-11-01 Dale Lind Fredell Antimicrobial compositions for mastitis control
US20030235560A1 (en) 2000-05-12 2003-12-25 Harrison Richard J. Mastitis prevention
US6589591B1 (en) 2001-07-10 2003-07-08 Baylor College Of Medicine Method for treating medical devices using glycerol and an antimicrobial agent
US20040186528A1 (en) 2003-03-20 2004-09-23 Medtronic, Inc. Subcutaneous implantable medical devices with anti-microbial agents for chronic release
US8449916B1 (en) 2009-11-06 2013-05-28 Iowa State University Research Foundation, Inc. Antimicrobial compositions and methods
US11364262B2 (en) * 2012-02-17 2022-06-21 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of skin trauma
US11672825B2 (en) * 2012-02-17 2023-06-13 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care
US10675299B2 (en) 2012-02-17 2020-06-09 Wiab Water Innovation Ab Hand disinfectant
BR112019012982A2 (pt) * 2016-12-22 2019-12-31 Wiab Water Innovation Ab composições compreendendo ácido acético e ácido hipocloroso e métodos para o tratamento de biofilmes

Also Published As

Publication number Publication date
IL282819A (en) 2021-06-30
WO2020089693A1 (en) 2020-05-07
AU2019371088A1 (en) 2021-06-17
CN113747889A (zh) 2021-12-03
CL2021001141A1 (es) 2022-03-18
JP2022506394A (ja) 2022-01-17
KR20220027799A (ko) 2022-03-08
PH12021551010A1 (en) 2021-10-04
CA3118187A1 (en) 2020-05-07
BR112021008550A2 (pt) 2021-08-03
MX2021005136A (es) 2021-10-13
EP3873450A1 (en) 2021-09-08

Similar Documents

Publication Publication Date Title
CL2021001141A1 (es) Composiciones para el tratamiento de biopelículas sin inducir resistencia antimicrobiana
PH12019501469A1 (en) Compositions and methods for treating biofilms
MX389697B (es) Nuevos derivados de pirazolopirimidina.
CY1124596T1 (el) Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση
MX387712B (es) Composicion y equipos para inhibicion de infeccion microbiana patogena y metodos para usar los mismos.
EA202091118A1 (ru) Антибактериальные соединения
MX386702B (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
CY1125704T1 (el) Ενωσεις c-μαννοσιδιου χρησιμες για τη θεραπεια μολυνσεων ουροποιητικης οδου
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
EP3566702A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES SUCH AS ASTHMA OR ATOPIA, CONSISTING OF BAICALEIN AS THE ACTIVE SUBSTANCE
CY1120003T1 (el) Αντιμικροβιακη πρωτεϊνη
BR112019001131A2 (pt) composto virucida, composição farmacêutica, método de desinfecção e/ou esterilização, dispositivo e uso dos compostos virucidas
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
EP3881849C0 (en) COMPOSITION COMPRISING AN APTAMER AS AN ACTIVE INGREDIENT FOR THE TREATMENT AND PREVENTION OF A DEGENERATIVE BRAIN DISEASE
EP3643302C0 (en) COMPOSITION COMPRISING A SESQUITERPENE DERIVATIVE AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MUSCULAR DISEASES
EA201991530A1 (ru) Композиции и способы лечения биопленок
CY1119308T1 (el) Συνδυασμοι με ενα πεπτιδιο κυκλοποιημενου σκελετου
EP3403656A4 (en) COMPOSITION FOR PREVENTING, HEALING OR TREATING THE FEMALE CLIMATE SYNDROME WITH LOGANINE OR DERIVATIVES THEREOF AS AN ACTIVE SUBSTANCE
EP3886804C0 (de) Wässrige zusammensetzung, insbesondere zur behandlung von schleimhaut und/oder wunden
EP3848029A4 (en) MEDICAL COMPOSITION FOR THE TREATMENT OF BRAIN ATTACKS
EP3639842A4 (en) Pharmaceutical composition containing gly-thymosin 4 (gly-t 4) for treatment of dry eye
EP4285910A4 (en) Pharmaceutical composition for treatment of neuroinflammation, comprising eleutheroside b as active ingredient
EA201891922A1 (ru) Лекарственное средство для лечения инфекций на фоне диабетической стопы